Concepedia

Author

Isamu Sugiura

Nagoya UniversityORCID

Also Known As

Etsuko Yamazaki, F Hayakawa, I Sugiura, I. Sugiura, Isamu SUGIURA, Isamu Sugiura, Masashi Sawa, Tetsuhito Kojima

130

Publications

2.1K

Citations

24

H-Index

55

Concepts

All Affiliations

Nagoya UniversityToyohashi Municipal HospitalKanagawa Cancer CenterKanagawa Prefectural Hospital OrganizationAichi Cancer Center
IS

About

Isamu Sugiura is an author at Nagoya University specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

16

377

2

Health Sciences

6

6

156

3

Natural Sciences

4

4

108

4

Engineering

1

1

13

5

Biochemistry

1

1

10

Isamu Sugiura

×

43

Publications

1.7K

Citations

21

H-Index

YearCitations

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed <i>BCR</i>-<i>ABL</i>–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura,

Journal of Clinical Oncology

2005

452

Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study

Shigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki,

Clinical Infectious Diseases

2015

147

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta,

Blood Advances

2020

117

Prospective monitoring of <i>BCR‐ABL1</i> transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib‐combined chemotherapy

Masamitsu Yanada, Isamu Sugiura, Jin Takeuchi,

British Journal of Haematology

2008

101

Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy

Masamitsu Yanada, J. Takeuchi, Isamu Sugiura,

Haematologica

2008

62

A phenotypically neutral dimorphism of protein S: The substitution of Lys155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene

Tomio Yamazaki, Isamu Sugiura, Tadashi Matsushita,

Thrombosis Research

1993

54

Trough plasma concentration of imatinib reflects BCR–ABL kinase inhibitory activity and clinical response in chronic‐phase chronic myeloid leukemia: A report from the BINGO study

Yuichi Ishikawa, Hitoshi Kiyoi, Keisuke Watanabe,

Cancer Science

2010

53

Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL

Yoshihiro Hatta, Shuichi Mizuta, Keitaro Matsuo,

Annals of Hematology

2018

47

Profactor IX Propeptide and Glutamate Substrate Binding Sites on the Vitamin K-dependent Carboxylase Identified by Site-directed Mutagenesis

Isamu Sugiura, Bruce Furie, Christopher T. Walsh,

Journal of Biological Chemistry

1996

39

Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan

Tsutomu Tanaka, Kazuyuki Shimada, Kazuhito Yamamoto,

Annals of Hematology

2011

38

Page 1